Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5282553
Max Phase: Preclinical
Molecular Formula: C15H10ClF5N2O2
Molecular Weight: 380.70
Associated Items:
ID: ALA5282553
Max Phase: Preclinical
Molecular Formula: C15H10ClF5N2O2
Molecular Weight: 380.70
Associated Items:
Canonical SMILES: O=C(Nc1ccc(OC(F)F)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1
Standard InChI: InChI=1S/C15H10ClF5N2O2/c16-12-6-3-9(7-11(12)15(19,20)21)23-14(24)22-8-1-4-10(5-2-8)25-13(17)18/h1-7,13H,(H2,22,23,24)
Standard InChI Key: NHVCOYVHDHWODF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 380.70 | Molecular Weight (Monoisotopic): 380.0351 | AlogP: 5.60 | #Rotatable Bonds: 4 |
Polar Surface Area: 50.36 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.54 | CX Basic pKa: | CX LogP: 5.37 | CX LogD: 5.37 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.68 | Np Likeness Score: -1.95 |
1. Du X, Wang M, Hu X, Nie T, Zhu M, Zhang G, You X, Wang Y.. (2022) Synthesis and biological evaluation of novel N, N'-diarylurea derivatives as potent antibacterial agents against MRSA., 75 [PMID:36067930] [10.1016/j.bmcl.2022.128975] |
Source(1):